ZX 4081
Alternative Names: ZX-4081Latest Information Update: 28 May 2025
At a glance
- Originator Nanjing Zenshine Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Phosphatidylinositol 3 kinase gamma inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammation; Solid tumours
Most Recent Events
- 28 May 2025 No recent reports of development identified for preclinical development in Inflammation in USA (PO)
- 28 Feb 2025 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (PO)
- 08 Apr 2022 Pharmacodynamics and pharmacokinetics data from a preclinical study in Solid tumours presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)